Mazindol and lidocaine are antinociceptives in the mouse formalin model: Involvement of dopamine receptor

European Journal of Pharmacology

Volumn 330, Issue 2-3, 1997, Pages 109-113

  Bittencourt, Alvorita L ^a   Takahashi, Reinaldo N ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antinociception; Dopamine; Formalin lest; Lidocaine; Mazindol; Opioid

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANOREXIGENIC AGENT; COCAINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FORMALDEHYDE; HALOPERIDOL; LIDOCAINE; LOCAL ANESTHETIC AGENT; MAZINDOL; NALOXONE; SULPIRIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANESTHETICS, LOCAL; ANIMALS; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; HALOPERIDOL; LIDOCAINE; MALE; MAZINDOL; MICE; NALOXONE; NARCOTIC ANTAGONISTS; NOCICEPTORS; PAIN MEASUREMENT; RECEPTORS, DOPAMINE; RECEPTORS, OPIOID;

EID: 0030871993     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00182-9     Document Type: Article

References (23)

1. Abbott F.V., Young S.N. Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin test. Pharmacol. Biochem. Behav. 31:1988;855-860.
2. Abbott F.V., Melzack R., Samuel C. Morphine analgesia in the tail-flick and formalin pain tests is mediated by different neural systems. Exp. Neurol. 75:1982;644-651.
3. Biella G., Sotgiu M.L. Central effects of systemic lidocaine mediated by glycine spinal receptors: An iontophoretic study in the rat spinal cord. Brain Res. 603:1993;201-206.
4. Biella G., Lacerenza M., Marchettini P., Sotgiu M.L. Diverse modulation by systemic lidocaine of iontophoretic NMDA and quisqualic acid induced excitations on rat dorsal horn neurons. Neurosci. Lett. 157:1993;207-210.
5. Dennis S.G., Melzack R. Pain modulation by 5-hydroxytryptaminergic agents and morphine as measured by three pain tests. Exp. Neurol. 69:1980;260-270.
6. Gerrits M.A.F.M., Zwartouw N.P.E.E., Van Ree J.M. Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology. 119:1995;92-96.
7. Graham J.H., Maher J.R., Robinson S.E. The effect of cocaine and other local anesthetics on central dopaminergic neurotransmission. J. Pharmacol. Exp. Ther. 27:1995;707-717.
8. 3H ] Mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes Eur. J. Pharmacol. 90:1983;461-462.
9. Kruk Z.L., Zarrindast M.R. Mazindol anorexia is mediated by activation of dopaminergic mechanisms. Br. J. Pharmacol. 58:1976;367-372.
10. 2+. Anesthesiology. 82:1995;166-173.
11. Lin Y., Morrow T.J., Kiritsy-Roy J.A., Terry L.C., Casey K.L. Cocaine: evidence for supraspinal, dopamine mediated, non opiate analgesia. Brain Res. 479:1989;306-312.
12. Mattei R., Carlini E.A. Mazindol: Anorectic and behavioral effects in female rats. Arch. Int. Pharmacodyn. Ther. 330:1995;279-281.
13. 2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link. Eur. J. Pharmacol. 187:1990;201-207.
14. Morgan M.J., Franklin K.B.J. 6-Hydroxydopamine lesions of the ventral tegmentum abolish d-amphetamine and morphine analgesia in the formalin test but not in the tail-flick test. Brain Res. 519:1990;144-149.
15. Paalzow G.H.M., Paalzow L.K. Opposing effects of apomorphine on pain in rats. Evaluation of the dose response curve. Eur. J. Pharmacol. 88:1983;27-35.
16. 2-adrenoceptor agonist, in various pain tests. Eur. J. Pharmacol. 179:1990;323-328.
17. 3H ]WIN35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GRB 12909 Eur. J. Pharmacol. 198:1991;203-205.
18. Rigon A.R., Takahashi R.N. The effects of systemic procaine, lidocaine and dimethocaine on nociception in mice. Gen. Pharmacol. 27:1996;647-650.
19. 2 dopamine receptor agonist RU 24926 and cross tolerance with morphine. Fundam. Clin. Pharmacol. 9:1995;147-152.
20. Tulunay F.C., Sparber S.B., Takemori A.E. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice. Eur. J. Pharmacol. 33:1975;65-70.
21. Woolf C.J., Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain. 23:1985;361-374.
22. Zambotti F., Carruba M.O., Barzaghi F., Vicentini L., Groppetti A., Mantegazza P. Behavioral effects of a new nonphenylethylamine anorexigenic agent: Mazindol. Eur. J. Pharmacol. 36:1976;405-412.
23. Zanin M., Takahashi R.N. Sex difference in sensitization to the locomotor effects of mazindol in rats. Brain Res. Bull. 34:1994;385-387.